Abstract:Objective: This study employs case data analysis to elucidate alterations in hormone levels pre and post-surgery among patients with pituitary adenoma. Moreover, it investigates the influence of various associated factors on endocrine function. Methods: A retrospective analysis was conducted on clinical data from 428 patients who underwent surgical treatment within a short period at a single center. Statistical methods were employed to examine detailed hormone level fluctuations before and after surgery in patients with pituitary adenoma, along with their interrelations with different factors. Results: Between January 2016 and October 2022, a total of 428 consecutive patients with pituitary adenoma underwent surgical treatment. Of these, 232 were males and 196 were females, with an average age of 45.91 years (range: 16-84, standard deviation: 12.18). Univariate analysis indicated that females exhibited a higher susceptibility to preoperative endocrine dysfunction (p < 0.05). Conversely, males, patients with larger tumor volumes, and older patients were more prone to preoperative pituitary insufficiency. Postoperatively, the most substantial remission rate occurred in prolactin (77.4%), followed by growth hormone (GH) (71.8%) and cortisol (4/6). The highest recovery rate in functions was observed in growth hormone secretion function (80%), followed by pituitary-adrenal axis hormone secretion function (56.3%) and pituitary-thyroid axis hormone secretion function (47.5%). The most noteworthy incidence of newly developed postoperative endocrine deficiencies was found in the pituitary-adrenal axis (31.8%), while the occurrence rates of deficiencies in other axes were relatively low. The elevated postoperative remission rate of growth hormone correlated with a higher surgical resection rate and lower preoperative growth hormone levels. Additionally, lower preoperative prolactin levels corresponded to a higher remission rate of prolactin postoperatively. Furthermore, the restoration of postoperative thyroid hormone secretion function was associated with higher preoperative free thyroxine levels. Reduced postoperative cortisol secretion function was linked to multiple surgeries and an extended interval between hormone retesting and surgery. Conclusion: Surgical intervention effectively ameliorates endocrine disorders in pituitary adenoma patients, thereby mitigating symptoms and enhancing their quality of life. Preoperative management of growth hormone and prolactin levels facilitates an increased remission rate of these hormones post pituitary adenoma surgery. Patients displaying preoperative thyroid hormone secretion dysfunction should be considered for active supplementation therapy. Whenever feasible, complete tumor resection is recommended. For patients undergoing reoperation or multiple surgeries, vigilant postoperative cortisol monitoring and supplementation should be thoughtfully administered.

Post-operative changes of the pituitary hormone level for pituitary adenoma patients

Perioperative hormone level changes and their clinical implications in patients with pituitary adenoma: a retrospective study of 428 cases at a single center

A Novel “total Pituitary Hormone Index” As an Indicator of Postoperative Pituitary Function in Patients Undergoing Resection of Pituitary Adenomas

Preliminary study of "overall levels of pituitary hormone" in non-functional pituitary adenoma patients

Effects of transsphenoidal surgery on anterior pituitary function in growth hormone-secreting pituitary adenomas and analysis of related factors

[Pituitary functional recovery and hormone replacement therapy of patients with pituitary adenoma surgery].

The effect of adenomectomy on endocrine hormones and evaluation of long term therapeutic efficacy

Perioperative Fluctuation and Overall Evaluation of Adenohypophyseal Hormone Secretion in Patients with Nonfunctioning Pituitary Adenoma.

Outcome of Postoperative Hypopituitarism and Hormone Replacement Situation in 215 Patients with Pituitary Adenoma

Observation on Curative Effect of Two Kinds of Surgical Methods of Pituitary Adenoma Resection

Pre- and Postoperative Health Status of Patients with Nonfunctioning and Secretory Pituitary Adenomas and an Analysis of Related Factors.

Clinical efficacy analysis of transsphenoidal neuroendoscopic surgery for pituitary adenoma

Functional protection during operations of pituitary adenoma

Pre- and Postoperative Magnetic Resonance Imaging Comparative Studies of Pituitary Tissues Following Transsphenoidal Resection of Pituitary Macroadenomas

Retinal Nerve Fiber Layer Changes after Transsphenoidal and Transcranial Pituitary Adenoma Resection

A Retrospective Analysis of Postoperative Hypokalemia in Pituitary Adenomas after Transsphenoidal Surgery

Effects of neuroendoscope-assisted surgery via single-nostril transsphenoidal approach for pituitary adenomas on the levels of peripheral blood T lymphocyte subsets and serum MMP-9

Nonfunctioning pituitary adenomas perioperative endocrine levels and diagnostic progress

Relationship Between the Hormones Changes in Patients with Craniopharyngioma Before the Surgery and Diabetes Lnsipidus after the Surgery

Evaluation of a Novel General Pituitary Hormone Score to Evaluate the Function of the Residual Anterior Pituitary (adenohypophysis) in Patients Following Surgery for Pituitary Adenoma.

Postoperative Complications of Endoscopic Transsphenoidal Pituitary Adenoma Resection